These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8627265

  • 21. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.
    Baldinotti F, Matteucci D, Mazzetti P, Giannelli C, Bandecchi P, Tozzini F, Bendinelli M.
    J Virol; 1994 Jul; 68(7):4572-9. PubMed ID: 8207831
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates.
    Osborne R, Rigby M, Siebelink K, Neil JC, Jarrett O.
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3641-5. PubMed ID: 7996159
    [Abstract] [Full Text] [Related]

  • 24. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA, LaVoy A, Burkhard MJ.
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
    Sparger EE, Beebe AM, Dua N, Himathongkam S, Elder JH, Torten M, Higgins J.
    Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
    [Abstract] [Full Text] [Related]

  • 27. B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.
    Pancino G, Chappey C, Saurin W, Sonigo P.
    J Virol; 1993 Feb; 67(2):664-72. PubMed ID: 7678301
    [Abstract] [Full Text] [Related]

  • 28. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.
    Tozzini F, Matteucci D, Bandecchi P, Baldinotti F, Poli A, Pistello M, Siebelink KH, Ceccherini-Nelli L, Bendinelli M.
    J Virol Methods; 1992 Jun; 37(3):241-52. PubMed ID: 1321834
    [Abstract] [Full Text] [Related]

  • 29. Feline immunodeficiency virus (FIV) neutralization: a review.
    Hosie MJ, Pajek D, Samman A, Willett BJ.
    Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
    Huisman W, Schrauwen EJ, Pas SD, van Amerongen G, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2008 May 19; 26(21):2553-61. PubMed ID: 18430494
    [Abstract] [Full Text] [Related]

  • 31. Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence.
    Hohdatsu T, Hirabayashi H, Motokawa K, Koyama H.
    J Gen Virol; 1996 Jan 19; 77 ( Pt 1)():93-100. PubMed ID: 8558132
    [Abstract] [Full Text] [Related]

  • 32. Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization.
    Giannecchini S, Matteucci D, Bendinelli M.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):199-204. PubMed ID: 9491909
    [Abstract] [Full Text] [Related]

  • 33. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
    Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, Clapham PR.
    J Virol; 1997 Sep 10; 71(9):6407-15. PubMed ID: 9261358
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.
    Richardson J, Moraillon A, Crespeau F, Baud S, Sonigo P, Pancino G.
    J Virol; 1998 Mar 10; 72(3):2406-15. PubMed ID: 9499101
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.
    Palker TJ, Muir AJ, Spragion DE, Staats HF, Langlois A, Montefiori DC.
    Virology; 1996 Oct 15; 224(2):415-26. PubMed ID: 8874502
    [Abstract] [Full Text] [Related]

  • 38. Examination of variables affecting syncytium formation by, and serum neutralization of, feline immunodeficiency virus on CrFK cells.
    Bandecchi P, Pistello M, Matteucci D, Lombardi S, Bendinelli M, Tozzini F.
    New Microbiol; 1995 Jul 15; 18(3):241-52. PubMed ID: 7553358
    [Abstract] [Full Text] [Related]

  • 39. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus.
    Vahlenkamp TW, De Ronde A, Schuurman NNMP, van Vliet ALW, van Drunen J, Horzinek MC, Egberink HF.
    J Gen Virol; 1999 Oct 15; 80 ( Pt 10)():2639-2646. PubMed ID: 10573157
    [Abstract] [Full Text] [Related]

  • 40. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT, Bolin RA, Kelly RG.
    Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.